Skip to main content
SpringerLink
Log in

Neuropathy in Diabetes

  • Living reference work entry
  • First Online:
Principles of Diabetes Mellitus

  • 595 Accesses

Abstract

Diabetes is the most common cause of sensory polyneuropathy in the United States, and can cause any type of focal, multifocal, or polyneuropathy. Etiology of neuropathy in diabetes continues to be an area of active investigation and is likely multifactorial. Treatment remains, first and foremost, control of blood glucose levels to the best extent possible. Otherwise, treatment is symptomatic in nature. At this time, no agents are available to promote nerve regeneration.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. http://www.idf.org/diabetesatlas/5e/

  2. http://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf

  3. Abbott CA, Malik RA, van Ross ER, Kulkarni J, Boulton AJ. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the UK. Diabetes Care. 2011;34:2220–4.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Selvarajah D, Cash T, Sankar A. The contributors of emotional distress in painful diabetic neuropathy. Diab Vasc Dis Res. 2014. doi:10.1177/1479164114522135.

    Google Scholar 

  5. Selvarajah D, Wilkinson ID, Emery CJ, Harris ND, Shaw PJ, Witte DR, Griffiths PD, Tesfaye S. Early involvement of the spinal cord in diabetic peripheral neuropathy. Diabetes Care. 2006;29:2664–9.

    Article  PubMed  Google Scholar 

  6. Wessels AM, Rombouts SA, Simsek S, Kuijer JP, Kostense PJ, Barkhof F, Scheltens P, Snoek FJ, Heine RJ. Microvascular disease in type 1 diabetes alters brain activation: a functional magnetic resonance imaging study. Diabetes. 2006;55:334–40.

    Article  CAS  PubMed  Google Scholar 

  7. Moran C, Beare R, Phan TG, et al. Type 2 diabetes mellitus and biomarkers of neurodegeneration. Neurology. 2015;85:1123–30.

    Article  CAS  PubMed  Google Scholar 

  8. Malik RA, Kallinikos P, Abbott CA, van Schie CH, Morgan P, Efron N, Boulton AJ. Corneal confocal microscopy: a non-invasive surrogate of nerve fiber damage and repair in diabetic patients. Diabetologia. 2003;46:683–8.

    CAS  PubMed  Google Scholar 

  9. Pittenger GL, Ray M, Burcus NI, McNulty P, Basta B, Vinik AI. Intraepidermal nerve fibers are indicators of small-fiber neuropathy in both diabetic and nondiabetic patients. Diabetes Care. 2004;27:1974–9.

    Article  PubMed  Google Scholar 

  10. Diabetes Control and Complications Trial (DCCT) Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86.

    Article  Google Scholar 

  11. Francis G, Martinez J, Liu W, Nguyen T, Ayer A, Fine J, Zochodne D, Hanson LR, Frey 2nd WH, Toth C. Intranasal insulin ameliorates experimental diabetic neuropathy. Diabetes. 2009;58:934–45.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Wu X, Zha D, Xiang G, Zhang B, Xiao SY, Jia R. Combined MMF and insulin therapy prevents renal injury in experimental diabetic rats. Cytokine. 2006;36:229–36.

    Article  CAS  PubMed  Google Scholar 

  13. Johansson BL, Borg K, Fernqvist-Forbes E, Kernell A, Odergren T, Wahren J. Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with type 1 diabetes mellitus. Diab Med. 2000;17:181–9.

    Article  CAS  Google Scholar 

  14. Gerstein HC, Miller ME, Byington RP, Goff Jr DC, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm Jr RH, Probstfield JL, Simons-Morton DG, Friedewald WT. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545–59.

    Article  CAS  PubMed  Google Scholar 

  15. Wile DJ, Toth C. Association of metformin, elevated homocysteine, methylmalonic acid levels and clinically worsened diabetic peripheral neuropathy. Diabetes Care. 2010;33:156–61.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Judzewitsch RG, Jaspan JB, Polonsky KS, et al. Aldose reductase inhibition improves nerve conduction velocity in diabetic patients. N Engl J Med. 1983;308:119–25.

    Article  CAS  PubMed  Google Scholar 

  17. Boulton AJM, Levin SR, Comstock JP. A multicenter trial of the aldose-reductase inhibitor, tolrestat, in patients with symptomatic diabetic neuropathy. Diabetologia. 1990;33:433–6.

    Article  Google Scholar 

  18. Dyck PJ, Sherman WR, Hallcher LM, et al. Human diabetic endoneurial sorbitol, fructose, and myoinositol related to sural nerve morphometry. Ann Neurol. 1980;8:590–6.

    Article  CAS  PubMed  Google Scholar 

  19. Yamagishi S, Masuta N, Okamoto K, Yagihashi S. Alterations of protein kinase C activity in the peripheral nerve of STZ-induced diabetic mice overexpressing human aldose reductase (abstract). Diabetes. 2001;50:A190.

    Article  Google Scholar 

  20. Yamagishi S, Uehara K, Otsuki S, Yagihashi S. Differential influence of increased polyol pathway on protein kinase C expressions between endoneurial and epineurial tissues in diabetic mice. J Neurochem. 2003;87:497–507.

    Article  CAS  PubMed  Google Scholar 

  21. Watkins PJ, Gayle C, Alsanjari N, et al. Severe sensory autonomic neuropathy and endocrinopathy in insulin dependent diabetes. Q J Med. 1999;88:795–804.

    Google Scholar 

  22. Kelkar P, Masood M, Parry GJ. Distinctive pathologic findings in proximal diabetic neuropathy (diabetic amyotrophy). Neurology. 2000;55:83–8.

    Article  CAS  PubMed  Google Scholar 

  23. Halestrap AP. Calcium, mitochondria, and reperfusion injury: a pore way to die. Biochem Soc Trans. 2006;34:232–7.

    Article  CAS  PubMed  Google Scholar 

  24. Li X-G, Zochodne DW. Microvacuolar neuronopathy is a post-mortem artifact of sensory neurons. J Neurocytol. 2003;32:393–8.

    Article  CAS  PubMed  Google Scholar 

  25. Yagihashi S, Kamijo M, Ido Y, et al. Effects of long-term aldose reductase inhibition on development of experimental diabetic neuropathy: ultrastructural and morphometric studies of sural nerve in streptozocin-induced diabetic rats. Diabetes. 1990;39:690–7.

    Article  CAS  PubMed  Google Scholar 

  26. Xu QG, Li X-Q, Kotecha SA, et al. Insulin as an in vivo growth factor. Exp Neurol. 2004;188:43–51.

    Article  CAS  PubMed  Google Scholar 

  27. Toth C, Brussee V, Zochodne DW. Remote neurotrophic support of epidermal nerve fibers in experimental diabetes. Diabetologia. 2006;49:1081–8.

    Article  CAS  PubMed  Google Scholar 

  28. Windebank AJ, Feldman EL. Diabetes and the nervous system. In: Aminoff M, editor. Neurology and general medicine. 3rd ed. Philadelphia: Churchill Livingstone; 2001.

    Google Scholar 

  29. Melton III LJ, Dyck PJ. Epidemiology. In: Dyck PJ, Thomas PK, et al., editors. Diabetic neuropathy. 2nd ed. Philadelphia: WB Saunders; 1999. p. 239–52.

    Google Scholar 

  30. Pasnoor M, Dimachkie MM, Kluding P, Barohn RJ. Diabetic neuropathy part 1. Neurol Clin. 2013;31:425–45.

    Article  PubMed Central  PubMed  Google Scholar 

  31. Dyck PJ, Karnes JL, O’Brien PC, et al. The Rochester Diabetic Neuropathy Study: reassessment of tests and criteria for diagnosis and staged severity. Neurology. 1992;42:1164–70.

    Article  CAS  PubMed  Google Scholar 

  32. Niakan E, Harati Y. Sympathetic skin response in diabetic peripheral neuropathy. Muscle Nerve. 1988;11:261–4.

    Article  CAS  PubMed  Google Scholar 

  33. Low PA, Benrud-Larson LM, Sletten DM, et al. Autonomic symptoms and diabetic neuropathy. Diabetes Care. 2004;27:2942–7.

    Article  PubMed  Google Scholar 

  34. Ewing DJ, Campbell IW, Clarke BF. The natural history of diabetic autonomic neuropathy. Q J Med. 1980;49:95–108.

    CAS  PubMed  Google Scholar 

  35. Aronson D. Pharmacologic modulation of autonomic tone: implications for the diabetic patient. Diabetologia. 1997;40:476–81.

    Article  CAS  PubMed  Google Scholar 

  36. Schnell O, Schwarz A, Becker DM, Standl E. Autoantibodies against autonomic nervous tissues in type 2 diabetes. Exp Clin Endocrinol Diabetes. 2000;108:181–6.

    Article  CAS  PubMed  Google Scholar 

  37. Wein TH, Albers JW. Diabetic neuropathies. Phys Med Rehabil Clin N Am. 2001;12(2):307–20.

    CAS  PubMed  Google Scholar 

  38. Tavaloki M, Begum P, McLaughlin J, Malik RA. Corneal confocal microscopy for the diagnosis of diabetic autonomic neuropathy. Muscle Nerve. 2015;52:363–70.

    Article  Google Scholar 

  39. Pascoe MK, Low PA, Windebank AJ, Litchy WJ. Subacute diabetic proximal neuropathy. Mayo Clin Proc. 1997;72:1123–32.

    Article  CAS  PubMed  Google Scholar 

  40. Said G, Goulon-Goeau C, Lacroix C, Moulonguet A. Nerve biopsy findings in different patterns of proximal diabetic neuropathy. Ann Neurol. 1994;35:559–69.

    Article  CAS  PubMed  Google Scholar 

  41. Dyck PJB, Windebank AJ. Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: new insights into pathophysiology and treatment. Muscle Nerve. 2002;25:477–91.

    Article  PubMed  Google Scholar 

  42. Sinnreich M, Taylor BV, Dyck PJB. Diabetic neuropathies. Classification, clinical features, and pathophysiological basis. Neurologist. 2005;11:63–79.

    Article  PubMed  Google Scholar 

  43. Kawagashira Y, Watanabe H, Oki Y, et al. Intravenous immunoglobulin therapy markedly ameliorates muscle weakness and severe pain in proximal diabetic neuropathy. J Neurol Neurosurg Psychiatry. 2007;78:899–901.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  44. Schaublin GA, Michet Jr CJ, Dyck PJ, Burns TM. An update on the classification and treatment of vasculitic neuropathy. Lancet Neurol. 2005;4:853–65.

    Article  PubMed  Google Scholar 

  45. Dyck PJB, O’Brien P, Bosch EP, et al. The multi-centre, double-blind controlled trial of IV methylprednisolone in diabetic lumbosacral radiculoplexus neuropathy. Neurology. 2006;66(5 Suppl 2):A191.

    Google Scholar 

  46. Stewart JD. Diabetic truncal neuropathy: topography of the sensory deficit. Ann Neurol. 1989;25:233–8.

    Article  CAS  PubMed  Google Scholar 

  47. Sun SF, Streib EW. Diabetic thoracoabdominal neuropathy: clinical and electrodiagnostic features. Ann Neuro. 1981;9:75.

    Article  CAS  Google Scholar 

  48. Longstreth GF. Diabetic thoracic polyradiculopathy. Best Pract Res Clin Gastroenterol. 2005;19:275–81.

    Article  PubMed  Google Scholar 

  49. Katz JS, Saperstein DS, Wolfe G, et al. Cervicobrachial involvement in diabetic radiculoplexopathy. Muscle Nerve. 2001;24:794–8.

    Article  CAS  PubMed  Google Scholar 

  50. Goldstein JE, Cogan DG. Diabetic ophthalmoplegia with special reference to the pupil. Arch Ophthalmol. 1960;64:592.

    Article  CAS  PubMed  Google Scholar 

  51. Jacobson DM. Pupil involvement in patients with diabetes-associated oculomotor nerve palsy. Arch Ophthalmol. 1998;116:723–7.

    Article  CAS  PubMed  Google Scholar 

  52. Richards BW, Jones FR, Younge BR. Causes and prognosis in 4,278 cases of paralysis of the oculomotor, trochlear, and abducens cranial nerves. Am J Ophthalmol. 1992;113:489.

    Article  CAS  PubMed  Google Scholar 

  53. Kanazawa A, Haginomori S, Takamaki A, et al. Prognosis for Bell’s palsy: a comparison of diabetic and nondiabetic patients. Acta Otolaryngol. 2007;127:888–91.

    Article  PubMed  Google Scholar 

  54. Stamboulis E, Vassilopoulos D, Kalfakis N. Symptomatic focal mononeuropathies in diabetic patients: increased or not? J Neurol. 2005;252:448–52.

    Article  PubMed  Google Scholar 

  55. Dahlin LB, Meiri KF, McLean WG, et al. Effects of nerve compression on fast axonal transport in streptozotocin-induced diabetes mellitus. Diabetologia. 1986;29:181–5.

    Article  CAS  PubMed  Google Scholar 

  56. Ozkul Y, Sabuncu T, Kocabey Y, et al. Outcomes of carpal tunnel release in diabetic and non-diabetic patients. Acta Neurol Scand. 2002;106:168–72.

    Article  CAS  PubMed  Google Scholar 

  57. Shahani B, Spalding JMK. Diabetes mellitus presenting with bilateral foot-drop. Lancet. 1969;2:930–1.

    Article  CAS  PubMed  Google Scholar 

  58. Kimura J. Electrodiagnosis in diseases of nerve and muscle: principles and practice. 3rd ed. New York: Oxford University Press; 2001.

    Google Scholar 

  59. Umapathi T, Tan WL, Loke SC, et al. Intraepidermal nerve fiber density as a marker of early diabetic neuropathy. Muscle Nerve. 2007;35:591–8.

    Article  CAS  PubMed  Google Scholar 

  60. Mehra S, Tavakoli M, Kallinikos PA, et al. Corneal confocal microscopy detects early nerve regeneration after pancreas transplantation in patients with type 1 diabetes. Diabetes Care. 2007;30:2608–12.

    Article  PubMed  Google Scholar 

  61. Pham M, Oikonomou D, Hornung B, et al. MR neurography detects diabetic neuropathy early and with proximal predominance. Ann Neurol. doi:10.1002/ana.24524.

    Google Scholar 

  62. Navarro X, Sutherland DE, Kennedy WR. Long-term effects of pancreatic transplantation on diabetic neuropathy. Ann Neurol. 1997;42:727–36.

    Article  CAS  PubMed  Google Scholar 

  63. Smith AG, Russell J, Feldman EL, et al. Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care. 2006;29:1294–9.

    Article  PubMed  Google Scholar 

  64. Ziegler D, Low PA, Litchy WJ, et al. Efficacy and safety of antioxidant treatment with alpha lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial. Diabetes Care. 2011;34(9):2054–60.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  65. Bril V, Buchanan RA. Long-term effects of ranirestat (AS-3201) on peripheral nerve function in patients with diabetic sensorimotor polyneuropathy. Diabetes Care. 2006;29:68–72.

    Article  CAS  PubMed  Google Scholar 

  66. Vinik AI, Bril V, Kempler P, et al. Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial. Clin Ther. 2005;27:1164–80.

    Article  CAS  PubMed  Google Scholar 

  67. Keen H, Payan J, Allawi J, et al. Treatment of diabetic neuropathy with gamma-linolenic acid. The gamma-Linolenic Acid Multicenter Trial Group. Diabetes Care. 1993;16:8–15.

    Article  CAS  PubMed  Google Scholar 

  68. Zochodne DW. Diabetes mellitus and the peripheral nervous system: manifestations and mechanisms. Muscle Nerve. 2007;36:144–66.

    Article  CAS  PubMed  Google Scholar 

  69. Ziegler D. Treatment of diabetic polyneuropathy. Ann N Y Acad Sci. 2006;1084:250–66.

    Article  CAS  PubMed  Google Scholar 

  70. Vinik A. Clinical review: use of antiepileptic drugs in the treatment of chronic painful diabetic neuropathy. J Clin Endocrinol Metab. 2005;90:4936–45.

    Article  CAS  PubMed  Google Scholar 

  71. McKeage K. Treatment options for the management of diabetic painful neuropathy: best current evidence. Curr Opin Neurol. 2007;20(5):553–7.

    Article  CAS  PubMed  Google Scholar 

  72. Gimbel JS, Richards P, Portenoy RK. Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial. Neurology. 2003;60:927–34.

    Article  CAS  PubMed  Google Scholar 

  73. Gilron I, Bailey JM, Tu D, et al. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med. 2005;352:1324–34.

    Article  CAS  PubMed  Google Scholar 

  74. Bosi E, Conti M, Vermigli C, et al. Effectiveness of frequency-modulated electromagnetic neural stimulation in the treatment of painful diabetic neuropathy. Diabetologia. 2005;48:817–23.

    Article  CAS  PubMed  Google Scholar 

  75. Weintraub MI, Herrmann DN, Smith AG, et al. Pulsed electromagnetic fields to reduce diabetic neuropathic pain and stimulate neuronal repair: a randomized controlled trial. Arch Phys Med Rehabil. 2009;90(7):1102–9.

    Article  PubMed  Google Scholar 

  76. Kluding PM, Pasnoor M, Singh R, et al. The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy. J Diabet Complications. 2012;26(5):424–9.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Attending Neurologist, Weill Cornell Medical College, 520 East 70th Street, Rm K-615, 10021, New York, NY, USA

    Michael Rubin

  2. Peripheral Neuropathy Center, Weill Cornell Medical College, New York, NY, USA

    Russell L. Chin

Authors
  1. Michael Rubin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Russell L. Chin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Rubin .

Editor information

Editors and Affiliations

  1. Lenox Hill Hospital Division of Endocrinology, New York, New York, USA

    Leonid Poretsky

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this entry

Cite this entry

Rubin, M., Chin, R.L. (2015). Neuropathy in Diabetes. In: Poretsky, L. (eds) Principles of Diabetes Mellitus. Springer, Cham. https://doi.org/10.1007/978-3-319-20797-1_23-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-20797-1_23-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Online ISBN: 978-3-319-20797-1

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation